aTyr Pharma, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 190K | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 394K | 0 | 22.1M | 0 | 0 | 12.2M | 0 | 0 |
| Gross Profit | -394K | 0 | -21.9M | 0 | 0 | -12.2M | 0 | 0 |
| R&D Expenses | 7.3M | 10.9M | 22.1M | 15.4M | 11.8M | 12.2M | 14.8M | 14.0M |
| Operating Expenses | 11.0M | 14.8M | 4.8M | 20.3M | 15.8M | 3.6M | 18.1M | 17.3M |
| Operating Income | -11.4M | -14.8M | -26.7M | -20.3M | -15.8M | -15.8M | -18.1M | -17.3M |
| Other Income / Gains | 645K | 832K | 999K | 781K | 892K | 852K | 882K | 1.0M |
| Net Income | -10.8M | -14.0M | -25.7M | -19.5M | -14.9M | -15.0M | -17.3M | -16.3M |
| EPS (Diluted) | -0.11 | -0.14 | -0.26 | -0.22 | -0.17 | -0.18 | -0.23 | -0.23 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | -115.474 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 4.1M | 3.9M | 4.8M | 4.9M | 4.0M | 3.6M | 3.3M | 3.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 4.1M | 3.9M | 4.8M | 4.9M | 4.0M | 3.6M | 3.3M | 3.3M |
| Other Expenses | -394K | 0 | -22.1M | 0 | 0 | -12.2M | 0 | 0 |
| Cost And Expenses | 11.4M | 14.8M | 26.9M | 20.3M | 15.8M | 15.8M | 18.1M | 17.3M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 394K | 394K | 165K | 387K | 383K | 175K | 388K | 383K |
| Ebitda | -10.4M | -13.6M | -25.6M | -19.1M | -14.5M | -14.8M | -16.9M | -15.9M |
| Ebitdaratio | 0 | 0 | -134.637 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | -140.763 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -10.8M | -14.0M | -25.7M | -19.5M | -14.9M | -15.0M | -17.3M | -16.3M |
| Income Before Tax Ratio | 0 | 0 | -135.505 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | -135.495 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.11 | -0.14 | -0.26 | -0.22 | -0.17 | -0.18 | -0.23 | -0.23 |
| Weighted Average Shs Out | 98.0M | 98.0M | 97.2M | 90.1M | 86.5M | 82.7M | 75.8M | 72.3M |
| Weighted Average Shs Out Dil | 98.0M | 98.0M | 97.2M | 90.1M | 86.5M | 82.7M | 75.8M | 72.3M |